ArticleCureus2025
Monomorphic Epitheliotropic Intestinal T-cell Lymphoma With Initial Pulmonary Symptoms: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Monomorphic epitheliotropic intestinal T-cell lymphoma (MEITL) is a rare and aggressive T-cell lymphoma that primarily affects the small intestine. Our case highlights a 60-year-old woman who initially presented with dyspnea, cough, and hemoptysis, followed by gastrointestinal symptoms during hospitalization. Imaging revealed cavitary lung masses, and biopsies confirmed MEITL with a TCR-delta+, CD8+, CD56+, and CD103+ immunophenotype. Endoscopy revealed duodenal nodularity and gastric ulcers; colonoscopy showed diffuse colonic inflammation. This case emphasizes the rare pulmonary involvement in MEITL and expands the limited literature on its extraintestinal manifestations. Clinicians should maintain a high index of suspicion for MEITL in patients presenting with both pulmonary and concurrent gastrointestinal complaints. Early recognition and biopsy-driven diagnosis are critical for timely intervention in this aggressive malignancy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.